Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CGEN
#3562
Compugen Ltd. - Ordinary Shares
2.3
6
USD
+0.03%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.61%
Monthly Change
+16.26%
6 month change
+2.61%
Year Change
+56.29%
Previous Close
2.3
0
Open
2.3
6
Low
2.3
6
High
2.3
6
Volume
10
Markets
US Stock Market
Healthcare
Biotechnology
CGEN
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 25
Total assets
156.57 M
Total liabilities
53.84 M
Total equity
102.73 M
Total liabilities & shareholders' equities
156.57 M
Total debt
—
Net debt
—
News
Compugen Ltd. (CGEN) Q1 2026 Earnings Call Transcript
Compugen (CGEN) Reports Q1 Loss, Lags Revenue Estimates
BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates
Adherex Technologies Inc. (FENC) Beats Q1 Earnings and Revenue Estimates
Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates
BioMarin Pharmaceutical (BMRN) Q1 Earnings Lag Estimates
Compugen at Leerink Global Healthcare Conference: Strategic Insights
Compugen Ltd. (CGEN) Q4 2025 Earnings Call Transcript
Morgan Stanley raises AstraZeneca stock price target on earnings growth
Compugen (CGEN) Beats Q4 Earnings and Revenue Estimates
Compugen earnings beat by $0.68, revenue topped estimates
Compugen stock jumps 5% on fourth quarter earnings beat